MENU
RemediumOne is proud to announce its role as a founding member of the COGNITUM ARO Consortium, a global alliance of seven leading research organizations. Officially launched during the European Society of Cardiology Congress 2023 in Amsterdam, this consortium is built on a shared vision: to harness scientific and clinical excellence in order to transform healthcare outcomes across diverse global communities.
As Sri Lanka’s representative in this network, RemediumOne brings its deep expertise in clinical research, regional insights, and operational excellence to the table, contributing to a collective mission to accelerate patient-centric healthcare solutions.
The Founding Member Institutions Include:
Centre for Chronic Disease Control (India)
CPC Clinical Research (USA)
Hospital Israelita Albert Einstein (Brazil)
ICTU-Global (UK)
The George Institute for Global Health (Australia/UK)
University of Cape Town (South Africa)
RemediumOne (Sri Lanka)
The consortium aims to leverage resources in Low- and Middle-Income Countries (LMICs) and ensure that studies are specifically designed with a focus on ethnicity and diversity. Furthermore, the consortium will provide the benefit of conducting decentralized trials, thereby offering enhanced flexibility.
Learn more about the COGNITUM ARO Consortium:
www.cognitumconsortium.org